Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
AXSM Axsome Therapeutics
- 131.150
- -0.530-0.40%
Close Feb 14 16:00 ET
- 131.090
- -0.060-0.05%
Post 20:01 ET
6.36BMarket Cap-19.93P/E (TTM)
132.120High129.350Low1.06MVolume131.610Open131.680Pre Close139.57MTurnover2.94%Turnover RatioLossP/E (Static)48.46MShares134.18552wk High68.41P/B4.75BFloat Cap64.11052wk Low--Dividend TTM36.23MShs Float134.185Historical High--Div YieldTTM2.10%Amplitude1.940Historical Low131.155Avg Price1Lot Size
Axsome Therapeutics News
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Insider Sale: Chief Financial Officer of $AXSM Sells 3,000 Shares
Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $195
Mizuho Adjusts Price Target on Axsome Therapeutics to $195 From $137, Keeps Outperform Rating
Earnings Preview: AXSM to Report Financial Results Pre-market on February 18
A Quick Look at Today's Ratings for Axsome Therapeutics(AXSM.US), With a Forecast Between $133 to $176
Express News | Wells Fargo Maintains Overweight on Axsome Therapeutics, Raises Price Target to $160
Express News | Deutsche Bank Initiates Coverage On Axsome Therapeutics With Buy Rating, Announces Price Target of $176
Why Axsome Therapeutics Stock Is Soaring Today
Earnings Preview: Axsome Therapeutics (AXSM) Q4 Earnings Expected to Decline
Axsome Therapeutics Is Maintained at Buy by B of A Securities
Axsome Therapeutics Price Target Raised to $167 From $143 at BofA
A Quick Look at Today's Ratings for Axsome Therapeutics(AXSM.US), With a Forecast Between $133 to $195
Truist Financial Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)
Mizuho Boosts Price Target on Axsome Therapeutics to $195 From $137, Keeps Outperform Rating
Express News | Axsome Therapeutics Inc : Mizuho Raises Target Price to $195 From $137
Analysts Offer Insights on Healthcare Companies: Progyny (PGNY) and Axsome Therapeutics (AXSM)
Analysts Conflicted on These Healthcare Names: Incyte (INCY), Axsome Therapeutics (AXSM) and Vertex Pharmaceuticals (VRTX)
Express News | Axsome Therapeutics Inc : Deutsche Bank Initiates Coverage With Buy Rating; Price Target $176
Axsome (AXSM) Surges 20.2%: Is This an Indication of Further Gains?
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.